Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Baxter International IncBAX-127.221.262.4414.57-2.22%0.09%54.67$37.02-$75.0089,334$36.92

Detail of Baxter International Inc

 
CEO
Mr. Jose E. Almeida
Employees
60000
Industry
Medical Instruments & Supplies
Sector
Healthcare
Market cap
$19B

Company details

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
OIE
PI
TAX
NI
Revenue (Rev)
$15.00B
Cost of goods (CoG)
-$9.59B
Gross profit (GP)
$5.41B
Operating expense (OE)
-$4.64B
Research and development (R&D)
-$687.00M
General and administrative (G&A)
-$3.95B
Other (OTH)
$3.00M
Operating income (OI)
$770.00M
Other income expense (OIE)
-$482.00M
Pretax income (PI)
-$75.00M
Tax (TAX)
-$73.00M
Net income (NI)
$2.48B
Baxter International Inc
BAX • XNYS • US
$36.92
+4.95 (15.49%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Dividend yield
3.14%
Trailing annual dividend rate
$1.16
Payout ratio
252.17%
EPS
-$0.29
Margin profit
16.51%
52 week low
$32.029999
52 week high
$43.77
50-day simple moving average
$37.09
200-day simple moving average
$37.02
Percent held by insiders
0.38%
Percent held by institutions
91.85%
Dividend yield
2.97%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
BAX +15.49%
eps change
BAX 0.00%